serw-MX  [xml]  
 


    
 DeCS Categories

D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.663 Pyrans .
D03.383.663.283 Benzopyrans .
D03.383.663.283.266 Chromones .
D03.383.663.283.266.450 Flavonoids .
D03.383.663.283.266.450.175 Benzoflavones .
D03.383.663.283.266.450.400 Isoflavones .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.150 Benzopyrans .
D03.633.100.150.266 Chromones .
D03.633.100.150.266.450 Flavonoids .
D03.633.100.150.266.450.175 Benzoflavones .
D03.633.100.150.266.450.400 Isoflavones .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.065 Androgen Antagonists .
D06.347.065.249 Androgen Receptor Antagonists .
D06.347.710 Prostaglandin Antagonists .
D10 Lipids .
D10.251 Fatty Acids .
D10.251.355 Fatty Acids, Unsaturated .
D10.251.355.255 Eicosanoids .
D10.251.355.255.550 Prostaglandins .
D10.251.355.255.550.775 Prostaglandins, Synthetic .
D10.251.355.255.550.775.450 Prostaglandins E, Synthetic .
D10.251.355.255.550.775.450.050 Arbaprostil .
D23 Biological Factors .
D23.469 Inflammation Mediators .
D23.469.050 Autacoids .
D23.469.050.175 Eicosanoids .
D23.469.050.175.725 Prostaglandins .
D23.469.050.175.725.775 Prostaglandins, Synthetic .
D23.469.050.175.725.775.450 Prostaglandins E, Synthetic .
D23.469.050.175.725.775.450.050 Arbaprostil .
D23.469.700 Prostaglandins, Synthetic .
D23.469.700.660 Prostaglandins E, Synthetic .
D23.469.700.660.050 Arbaprostil .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.089 Acetaldehyde Dehydrogenase Inhibitors .
D27.505.519.389.108 Adenylyl Cyclase Inhibitors .
D27.505.519.389.870 Steroid Synthesis Inhibitors .
D27.505.519.389.892 Topoisomerase Inhibitors .
D27.505.519.389.892.500 Topoisomerase I Inhibitors .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.437 Neurotransmitter Uptake Inhibitors .
D27.505.519.562.437.850 Serotonin Uptake Inhibitors .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.600 Neurotransmitter Uptake Inhibitors .
D27.505.519.625.600.850 Serotonin Uptake Inhibitors .
D27.505.519.625.850 Serotonin Agents .
D27.505.519.625.850.900 Serotonin Uptake Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.065 Androgen Antagonists .
D27.505.696.399.450.065.249 Androgen Receptor Antagonists .
D27.505.696.399.450.710 Prostaglandin Antagonists .
D27.505.696.399.450.855 Steroid Synthesis Inhibitors .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.600 Neurotransmitter Uptake Inhibitors .
D27.505.696.577.600.850 Serotonin Uptake Inhibitors .
D27.505.696.577.850 Serotonin Agents .
D27.505.696.577.850.900 Serotonin Uptake Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.794 Topoisomerase Inhibitors .
D27.505.954.248.794.500 Topoisomerase I Inhibitors .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Benzoflavones .
Benzoflavone Compounds .
Compounds, Benzoflavone .
Organic compounds containing a BENZENE ring attached to a flavone group. Some of these are potent arylhydrocarbon hydroxylase inhibitors. They may also inhibit the binding of NUCLEIC ACIDS to BENZOPYRENES and related compounds. The designation includes all isomers; the 7,8-isomer is most frequently encountered. .
1.00
01219
 
Androgen Receptor Antagonists .
Antagonists, Androgen Receptor .
Receptor Antagonists, Androgen .
Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. .
0.40
01050
 
Steroid Synthesis Inhibitors .
Adrenal Steroid Synthesis Inhibitors .
Androgen Synthesis Inhibitors .
Estrogen Synthesis Inhibitors .
Glucocorticoid Synthesis Inhibitors .
Mineralocorticoid Synthesis Inhibitors .
Progestin Synthesis Inhibitors .
Sex Hormone Synthesis Inhibitors .
Steroid Synthesis Antagonists .
Steroid Synthesis Blockers .
Antagonists, Steroid Synthesis .
Blockers, Steroid Synthesis .
Inhibitors, Androgen Synthesis .
Inhibitors, Estrogen Synthesis .
Inhibitors, Glucocorticoid Synthesis .
Inhibitors, Mineralocorticoid Synthesis .
Inhibitors, Progestin Synthesis .
Inhibitors, Steroid Synthesis .
Synthesis Antagonists, Steroid .
Synthesis Blockers, Steroid .
Synthesis Inhibitors, Androgen .
Synthesis Inhibitors, Estrogen .
Synthesis Inhibitors, Glucocorticoid .
Synthesis Inhibitors, Mineralocorticoid .
Synthesis Inhibitors, Progestin .
Synthesis Inhibitors, Steroid .
nibidores da Síntese de Glucocorticoides .
Compounds that bind to and inhibit enzymes involved in the synthesis of STEROIDS. .
0.40
220
 
Adenylyl Cyclase Inhibitors .
Adenylate Cyclase Inhibitors .
Cyclase Inhibitors, Adenylate .
Cyclase Inhibitors, Adenylyl .
Inhibitors, Adenylate Cyclase .
Inhibitors, Adenylyl Cyclase .
Compounds that bind to and inhibit the action of ADENYLYL CYCLASES. .
0.39
02850
 
Prostaglandin Antagonists .
Antagonists, Prostaglandin .
Inhibitors, Prostaglandin .
Prostaglandin Antagonist .
Prostaglandin Inhibitor .
Antagonist, Prostaglandin .
Inhibitor, Prostaglandin .
Prostaglandin Inhibitors .
Compounds that inhibit the action of prostaglandins. .
0.37
292635
 
Isoflavones .
3-Benzylchroman-4-Ones .
3-Benzylidene-4-Chromanones .
Isoflavone Derivatives .
3 Benzylchroman 4 Ones .
3 Benzylidene 4 Chromanones .
Derivatives, Isoflavone .
Homoisoflavones .
3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. .
0.37
1178591
 
Acetaldehyde Dehydrogenase Inhibitors .
Acetaldehyde Dehydrogenase Antagonists .
Aldehyde Dehydrogenase Blockers .
Dehydrogenase Antagonists, Acetaldehyde .
Dehydrogenase Blockers, Aldehyde .
Dehydrogenase Inhibitors, Acetaldehyde .
Compounds that bind to and inhibit the enzymatic activity of acetaldehyde dehydrogenases. .
0.36
019
 
Serotonin Uptake Inhibitors .
Inhibitors, 5-HT Uptake .
Inhibitors, 5-Hydroxytryptamine Uptake .
Inhibitors, Serotonin Reuptake .
Inhibitors, Serotonin Uptake .
Reuptake Inhibitors, Serotonin .
Selective Serotonin Reuptake Inhibitors .
Uptake Inhibitors, 5-HT .
Uptake Inhibitors, 5-Hydroxytryptamine .
Uptake Inhibitors, Serotonin .
5 HT Uptake Inhibitors .
5 Hydroxytryptamine Uptake Inhibitors .
Inhibitors, 5 HT Uptake .
Inhibitors, 5 Hydroxytryptamine Uptake .
Uptake Inhibitors, 5 HT .
Uptake Inhibitors, 5 Hydroxytryptamine .
Serotonin Reuptake Inhibitors .
5-Hydroxytryptamine Uptake Inhibitors .
5-HT Uptake Inhibitors .
Compounds that specifically inhibit the reuptake of serotonin in the brain. .
0.36
20917644
 
Topoisomerase I Inhibitors .
DNA Topoisomerase I Inhibitors .
DNA Type 1 Topoisomerase Inhibitors .
Inhibitors, Topoisomerase 1 .
Inhibitors, Topoisomerase I .
Topoisomerase 1 Inhibitors .
Compounds that inhibit the activity of DNA TOPOISOMERASE I. .
0.36
32846
 
Arbaprostil .
Arbacet .
U-42842 .
15 Methylprostaglandin E2 .
U 42842 .
U42842 .
15-Methylprostaglandin E2 .
A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors. .
0.35
080